Influence of SLCO1B1 (OATP1B1/OATP-C) gene polymorphisms on cholesterol responses to atorvastatin.

被引：0
|
作者：
Zineh, I [1 ]
Langaee, TY [1 ]
Wessel, TR [1 ]
Arant, CB [1 ]
Schofield, RS [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P5 / P5
页数：1
相关论文
共 50 条
  • [1] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    S P R Romaine
    K M Bailey
    A S Hall
    A J Balmforth
    The Pharmacogenomics Journal, 2010, 10 : 1 - 11
  • [2] The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
    Romaine, S. P. R.
    Bailey, K. M.
    Hall, A. S.
    Balmforth, A. J.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (01): : 1 - 11
  • [3] Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)
    Niemi, M
    Kivistö, KT
    Hofmann, U
    Schwab, M
    Eichelbaum, M
    Fromm, MF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 602 - 604
  • [4] HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
    Hartkoorn, Ruben C.
    San Kwan, Wai
    Shallcross, Victoria
    Chaikan, Ammara
    Liptrott, Neill
    Egan, Deirdre
    Sora, Enrique Salcedo
    James, Chloe E.
    Gibbons, Sara
    Bray, Pat G.
    Back, David J.
    Khoo, Saye H.
    Owen, Andrew
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (02): : 112 - 120
  • [5] Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)
    Iwai, M
    Suzuki, H
    Ieiri, I
    Otsubo, K
    Sugiyama, Y
    PHARMACOGENETICS, 2004, 14 (11): : 749 - 757
  • [6] Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype*17
    Niemi, M
    Neuvonen, PJ
    Hofmann, U
    Backman, JT
    Schwab, M
    Lütjohann, D
    von Bergmann, K
    Eichelbaum, M
    Kivistö, KT
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (05): : 303 - 309
  • [7] Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1)
    Karlgren, Maria
    Ahlin, Gustav
    Vildhede, Anna
    Artursson, Per
    DRUG METABOLISM REVIEWS, 2010, 42 : 305 - 306
  • [8] WITHDRAWN POLYMORPHISMS OF SLCO1B1, ENCODING MEMBRANE TRANSPORTER PROTEIN OATP1B1, ASSOCIATE WITH BLADDER CANCER SUSCEPTIBILITY
    Fujimoto, Naohiro
    Bui, Hoai
    Kubo, Tatsuhiko
    Tomisaki, Ikko
    Matsumoto, Tetsuro
    JOURNAL OF UROLOGY, 2014, 191 (04): : E428 - E428
  • [9] In vivo role of human organic anion transporting polypeptide 1B1 (OATP1B1/SLCO1B1) and its murine orthologue Oatp1b2 to atorvastatin disposition
    DeGorter, Marianne K.
    Schwarz, Ute I.
    Tirona, Rommel G.
    Kim, Richard B.
    DRUG METABOLISM REVIEWS, 2009, 41 : 183 - 184
  • [10] Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
    Kameyama, Y
    Yamashita, K
    Kobayashi, K
    Hosokawa, M
    Chiba, K
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 513 - 522
12345